" rel="stylesheet">
Skip Main Navigation
Page Content
This event has ended

Orange County Summit on Regenerative Medicine


Thursday, September 26, 2013 from 10:00 AM to 6:00 PM (PDT)

Orange County Summit on Regenerative Medicine

Ticket Information

Ticket Type Sales End Price Fee Quantity
UCI Faculty & Students Ended $50.00 $0.00
OCTANe Members & Sponsors Ended $75.00 $0.00
General Admission Ended $125.00 $0.00
1 Year OCTANe Membership + Program Admission Ended $375.00 $0.00

Who's Going

Loading your connections...

Share Orange County Summit on Regenerative Medicine

Event Details

 stemcell              Stradling resized         


Sue and Bill Gross Stem Cell Research Center and OCTANe present:

1st Orange County Summit on Regenerative Medicine

Orange County's UC Irvine Sue and Bill Gross Hall researchers have attracted multi-million dollar grant funding:

  • Dr. Henry Klassen received $17.3M for stem cell work to treat the blinding effects of retinitis pigments. 
  • StemCells Inc., Dr. Frank LaFerla and Dr. Mathew Blurton-Jones received $20M to treat Alzheimer's disease. 
  • Dr. Aileen Anderson and Dr. Brian Cummings received $20M for spinal cord injury clinical trials. 

Orange County's UC Irvine has pioneered both the 1st FDA-approved human clinical trials for embryonic stem and neural progenitor cell-based therapies in the world.

Yet Orange County and California stand at a critical juncture.  Researchers, entrepreneurs, investors, policy makers, and service providers must work together now, or miss a tremendous opportunity to shape the future!

Join us and 130 registered attendees for this valuable program. 

Come and learn about the groundbreaking research at the Sue and Bill Gross Stem Cell Research Center.  The meeting will provide insight on current legal and intellectual property issues as well as commercialization efforts from leaders and local entrepreneurs. 

Main program starts 11:30 a.m. at the Beckman Center.  Registered attendees have the opportunity to tour the UC Irvine Stem Cell Research Center at UCI's Gross Hall beginning earlier from 10:00 a.m. to 11:00 a.m.. Please look for email about this after registration and respond. 



World-renowned stem cell researcher and entrepreneur Hans Keirstead, Professor of Anatomy and Neurobiology & Neurological Surgery, University of California – Irvine and Leader, California Stem Cell Inc., will lead the lineup.  Dr. Keirstead produced the research behind the world’s first FDA-approved clinical trial of human embryonic stem cell therapy for acute spinal cord injury and is pioneering commercial applications of stem cell research at California Stem Cell. 

The meeting will feature Sidney Golub, new Director of the Sue and Bill Gross Stem Cell Research Center. Dr. Golub is Professor Emeritus, Microbiology & Molecular Genetics School of Medicine and Chair of the UCI Human Stem Cell Research Committee.

The meeting wilellenl also feature Regenerative Medicine authority Ellen Feigal, VP of R&D at the California Institute for Regenerative Medicine (CIRM). Dr. Feigal has a track record of bringing together cross-functional therapeutic research teams at Amgen, where she was Executive Medical Director, and has performed executive roles at the National Cancer Institute and Translational Genomics Research I Institute. 

Nine individual regenerative medicine experts will present on their specific fields of study and the translational impact that this research is likely to have on the treatment of patients and disease states.  The day will conclude with a comprehensive panel of regulatory, clinical, academic, and industry experts on the future of regenerative medicine commercialization followed by a networking reception. 



Gross Hall: A CIRM Institute 845 Health Sciences Road Irvine, CA 92697

Arnold and Mabel Beckman Center of the National Academies of Sciences and Engineering, 100 Academy Dr., Irvine, CA 92617



If you responded you will be participating in the Gross Hall tour from 10:00 a.m. - 11:00 a.m., please look for a follow-up email about obtaining a complimentary temporary UCI parking slip for parking near Gross Hall after you register otherwise risk getting a parking ticket from UCI. 

Main program is at the Beckman Center from 11:30 a.m. - 6:00 p.m..  Beckman Center parking is free.



10:00 a.m. – 11:15 a.m.

Gross Hall Registration, Faculty Posters, and Sue and Bill Gross Stem Cell Research Center Tours

Gross Hall

11:30 a.m. – 12:30 p.m.

Beckman Center Registration, Exhibition, and Networking

Beckman Center Atrium

11:30 a.m. – 12:30 p.m.


Beckman Center Courtyard

12:30 p.m. – 1:00 p.m.

Welcome Luncheon Address

Hans Keirstead, Ph.D., Leader, California Stem Cell

Professor, Sue and Bill Gross Stem Cell Research Center, UCI

Beckman Center Auditorium

1:00 p.m. – 1:30 p.m.

State of Industry Address

Ellen Feigal, M.D., Senior VP R&D, CIRM


1:30 p.m. – 2:35 p.m.

(15 min. each)

Diabetes and Neurodegeneration

  • Ping Wang, M.D., Director, UCI Diabetes Center, UCI
  • Mathew Blurton-Jones, Ph.D., Assistant Professor, Neurobiology & Behavior, UCI
  • Charlie Limoli, Ph.D. Professor, Radiation Oncology, UCI
  • Edwin Monuki, M.D., Ph.D., Associate Professor, Pathology, UCI


2:35 p.m. – 2:50 p.m.

Exhibition Break

 Beckman Atrium

2:50 p.m. – 3:20 p.m.


Future of Stem Cell Research at UC - Irvine


Sidney Golub, Ph.D., Director Sue and Bill Gross Stem Cell Research Center

Beckman Center Auditorium

3:20 p.m. – 4:40 p.m.

(15 min. each)

Stem Cell Delivery and Bioengineering

  • Mike West, Ph.D., CEO, BioTime, Inc.
  • Maksim Plikus, Ph.D. Assistant Professor, Developmental & Cell Biology, UCI
  • Henry Klassen, M.D. Ph.D., Director, Stem Cell and Retinal Regeneration Program, UCI
  • Weian Zhao, Ph.D., Assistant Professor, Pharmaceutical Sciences, UCI
  • Lisa Flanagan, Ph.D., Assistant Professor, Neurology, UCI

4:40 p.m. – 5:15 p.m.

Future of Regenerative Medicine Commercialization: OC and global

Regulatory (Ellen Feigal, M.D., Senior VP R&D, CIRM)

Industry (Mike West, Ph.D., CEO, BioTime, Inc.)

Industry (Habib Torfi, CEO, Invitrx)

Academic (Frank LaFerla Ph.D., Chancellor’s Professor and Chair, Neurobiology & Behavior, UCI)

Clinical (Edwin Monuki, M.D., Ph.D., Associate Professor, Pathology, UCI)


5:15 p.m. – 5:20 p.m.

Concluding Comments

Matthew Jenusaitis, CEO & President, OCTANe


5:20 p.m. – 6:00 p.m.

Wine Reception & Exhibition

Beckman Center Atrium



Mathew Blurton-Jones, Ph.D. - Assistant Professor of Neurobiology & Behavior, University of California - Irvine
Dr. Blurton-Jones previously showed that neural stem cell transplantation can improve learning and memory in a transgenic mouse model of advanced Alzheimer’s disease. Blurton-Jones lab studies revealed that the stem cells helped promote recovery by elevating levels of a key protein, brain-derived neurotrophic factor (BDNF). 

Lisa Flanagan, Ph.D. - Assistant Professor of Neurology, University of California – Irvine
Dr. Flanagan’s research program combines the fields of neural cell biology and bioengineering to address issues critical to the successful transplantation of neural stem cells (NSCs) for the rep
air of injured or diseased central nervous system (CNS) tissue.

Sidney Golub, Ph.D. - Director of the Sue and Bill Gross Stem Cell Research Center. 

Dr. Golub is Professor Emeritus, Microbiology & Molecular Genetics School of Medicine and Chair of the UCI Human Stem Cell Research Committee.  His academic focus is on how policy on human stem cells including embryonic and other pluripotent stem cells is implemented and made.

ellenEllen Feigal, M.D. - VPof R&D, California Institute for Regenerative Medicine
Dr. Ellen G. Feigal is the Vice President, Research and Development at the California Institute for Regenerative Medicine (CIRM). Prior to joining CIRM in January, 2011, Dr. Feigal was Executive Medical Director, Global Development, at Amgen, where her primary focus was in clinical development of therapeutics in hematology/oncology.

Hans Keirstead, Ph.D. - Professor of Anatomy and Neurobiology & Neurological Surgery, University of California – Irvine; Leader, California Stem Cell
An internationally known stem cell expert, Hans Keirstead has pioneered a number of efforts in the field. He led his team of researchers to successfully develop a stem cell-based treatment for paralyzed rats. This treatment marked the first such stem cell-based clinical trial ever approved by a regulatory body, worldwide.

 Henry Klassen, M.D., Ph.D. - Associate Professor of Ophthalmology and Director of the Stem Cell and Retinal Regeneration Program, University of California - Irvine
Dr. Klassen’s research has shown that CNS progenitor cells are to some extent immune privileged, are neuroprotective to host photoreceptors, and also provide local cell replacement, notably of rods. We are now in the process of showing how such cells can be derived from human tissue, expanded greatly in culture, tested for safety and efficacy, then transplanted to the diseased eye.

Charles Limoli, Ph.D. - Professor of Radiation Oncology, University of California - Irvine
Dr. Limoli’s research program is focused on understanding the molecular mechanisms that underlie the mammalian stress response and how disruptions to this tightly regulated process lead to genomic instability and cancer. Central to his investigations is the identification of the mechanisms by which cells perpetuate genomic instability.

Frank LaFerla, Ph.D. - Chancellor’s Professor and Chair of Neurobiology & Behavior and Director of Institute for Memory Impairments & Neurological Disorders, University of California - Irvine
Dr. LaFerla’s lab is predominantly interested in elucidating the molecular basis underlying age-related disorders of the brain and skeletal muscle.  The major focus of our research is on Alzheimer’s disease and related dementias.  However, we also focus on inclusion body myositis (IBM), the most common age-related muscle disease, which shares some remarkable biochemical features with Alzheimer’s disease.

Edwin Monuki, M.D., Ph.D - Associate Professor and Chair of Pathology, Developmental and Cell Biology, and Biological Sciences, University of California – Irvine
The goals of the Monuki Laboratory are two-fold. The first goal is to understand how the brain develops. The second is use this understanding to make brain cells that might be useful for treating patients. One cell type of particular interest is the choroid plexus epithelial cell, which has significant untapped potential for treating neurodegenerative disorders such as Alzheimer’s Disease.

Maksim Plikus Ph.D. - Assistant Professor of Developmental & Cell Biology, University of California – Irvine
Dr. Plikus’ lab is interested in understanding the nature of stem cell regulatory networks and their role in regeneration. Instead of focusing on individual stem cells, his lab studies the activities of thousands of stem cells at the same time. To do so his laboratory is using the model of hair regeneration where all hair stem cells in the skin can be studied as a single network. Hair stem cells within the networks regenerate by forming patterns.
Michael D. West, Ph.D. - CEO, BioTime, Inc.
Dr. West became Chief Executive Officer of BioTime, Inc. during October 2007, and has served on the Board of Directors since 2002. Prior to becoming CEO, Dr. West served as Chief Executive Officer, President, and Chief Scientific Officer of Advanced Cell Technology, Inc., a company engaged in developing human stem cell technology for use in regenerative medicine.

Ping H Wang, M.D. - Director of UCIrvine Diabetes Center and Professor of Medicine, Biological Chemistry, Physiology & Biophysics, and Experimental Pathology, UCI
Dr. Ping Wang’s lab seeks to develop new methods to prevent, treat, and eventually cure diabetes and its complications through hormonal signaling, programming and reprogramming of stem cells molecular mechanisms of diabetes and its complications.

Weian Zhao, Ph.D. - Assistant Professor of Pharmaceutical Sciences, University of California – Irvine
Dr. Zhao’s lab is focused on mesenchymal stem cell therapy, tumor targeting and detection, and point-of-care diagnostics for global health. We aim to understand the biological, therapeutic and detrimental functions of transplanted stem cells in vivo, which will eventually allow us to better utilize them to treat a variety of diseases including cancer and stroke. Furthermore, we are developing bioengineered tools including microfluidics, nanoparticles and aptamers to tackle unmet challenges in disease diagnosis and global health.

Lunch and appetizers will be served.

For sponsorship and/or exhitition opportunities, please contact Christina Alexopoulos (949) 330-6566 or Christina@OCTANeOC.org

Have questions about Orange County Summit on Regenerative Medicine? Contact OCTANe

When & Where

Beckman Center
100 Academy Drive
Irvine, CA 92617

Thursday, September 26, 2013 from 10:00 AM to 6:00 PM (PDT)

  Add to my calendar
Orange County Summit on Regenerative Medicine
Irvine, CA Events Conference

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.